Article Per Year (5 Year)
p-Index From 2021 - 2026
1.829
P-Index
This Author published in this journals
All Journal Journal of Pharmaceutical Care Anwar Medika Jurnal Insan Farmasi Indonesia Pharmademica: Jurnal Kefarmasian dan Gizi Farmasis: Jurnal Sains Farmasi Jurnal Bakti Untuk Negeri Prosiding Seminar Nasional Pengabdian Masyarakat Abdi Wina : Jurnal Pengabdian Kepada Masyarakat Universitas Kristen Wira Wacana Sumba JOURNAL OF HEALTH MANAGEMENT RESEARCH Jurnal Ilmu Pengetahuan dan Teknologi Bagi Masyarakat Folia Medica Indonesiana
Amarullah, Adinugraha
Unknown Affiliation
Agriculture, Biological Sciences & Forestry Arts Humanities Biochemistry, Genetics & Molecular Biology Chemistry Computer Science & IT Dentistry Earth & Planetary Sciences Economics, Econometrics & Finance Education Health Professions Immunology & microbiology Industrial & Manufacturing Engineering Languange, Linguistic, Communication & Media Law, Crime, Criminology & Criminal Justice Medicine & Pharmacology Neuroscience Nursing Physics Public Health Social Sciences Veterinary

Published : 11 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 11 Documents
Search

 1   2 
Children with Standard Risk Acute Lymphoblastic Leukemia in Induction And Consolidation Phase Amarullah, Adinugraha; Hasmono, Didik; Ugrasena, IGD; Yulistiani, Yulistiani
Folia Medica Indonesiana Vol. 54, No. 1
Publisher : Folia Medica Indonesiana

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Prednisone has an important role in the therapy of patient with standard risk ALL. Patients with standard risk ALL receiving high dose prednisone as therapy and supraphysiology dose of prednisone are expected to cause suppression in HPA-axis (Hypothalamic Pituitary Adrenal axis). This suppression could reduce immune system in children with ALL and increase infection risk because reduction of cortisol level. In Indonesia, we did not find study about the incident of adrenal suppression after high dose prednisone therapy, especially in induction to consolidation phase ALL patient. The aim of this study was to analyze adrenal suppression after high dose prednisone therapy on children with standard risk acute lymphoblastic leukemia in induction and consolidation phase. This study has received a certificate of Ethical Clearance No. 588/Panke.KKE/X/2016, a longitudinal observational, prospective, non-randomized trial involving children with ALL who received prednisone for 49 days during the induction phase. We collected and compared laboratory result of cortisol level in children with ALL and received prednisone therapy during induction to consolidation phase. Sample was taken at week 0,4,5,6,7,8,10,12 in the course of ALL chemotheraphy Indonesian protocol year 2013. Serum was examined using methods CLIA ADVIA Centaur® XP. Between June 2016 – January 2017, 13 patients (8 males, 5 females) were included in this study. Decrease of cortisol level after prednisone therapy occured in week-10 as much as 53% compared with week-0 (p=0.027). Cortisol level increased 64% of week-12 compared with week-10 (p=0.003). In conclusion, high dose prednisone is not significant to causing adrenal suppression in induction phase of ALL patients, and the reducing cortisol level is reversible.
Co-Authors Aaliyah, Reza Ambari, Yani Anindhita, Puspita Raras Anwari, Farida Ardian, Yohanes Arista Wahyu Ningsih Aristia, Bela Fevi Auliya, Defina Zahrotul Battista Leki, Karol Giovani DEWI RAHMAWATI Didik Hasmono Febriyana, Sitti Fauziyah Febriyani, Dwi Fickri, Djelang Zainuudin Herni Setyawati Jannah, Ananda Kurniatul Kusuma Wardani, Deva Rahayu Nurindah Lestari, Mila Ayu Puji Maghfiroh, Firda Intan Nabila, Destiya Dwi Nanda, Fasya Nabila Putra Tawakal, Muhamad Aulia Putra, Muhammad Aulia Rahmawati, Reka Putri Rohmah, Atina Wahdatar Samudra, Rachmat Fadil Seran, Agustinus Alfred Seran, Ivan Charles Tawakal, Muhamad Aulia Putra Ugrasena, IGD Wahyuni, Khurin In Yulistiani Yulistiani, Yulistiani